Quantcast

Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN


Shutterstock photo

Top Health Care Stocks:

JNJ: -0.43%

PFE: -0.74%

ABT: -0.13%

MRK: -0.76%

AMGN: Flat

Most health care giants were lower in Friday's pre-bell trade.

Stocks moving on news include:

(+) Achillion Pharmaceuticals ( ACHN ), which was gaining over 7% in value as the company said interim data from a phase 2 trial showed its ACH-4471 combined with intravenous eculizumab increased hemoglobin and nearly eliminated the need for transfusions in patients with paroxysmal nocturnal hemoglobinuria, a blood disease.

(+) Outlook Therapeutics ( OTLK ) was more than 18% higher after the biopharmaceutical company reported a Q2 adjusted loss of $0.58 per share, which narrowed than the year-ago net loss of $2.15 per share and the consensus estimate provided by Capital IQ for a loss of $0.66 per share.

(-) MorphoSys ( MOR ) was declining by more than 3% even after saying the results of the L-MIND single-arm phase 2 clinical trial assessing the antibody tafasitamab, or MOR208, combined with lenalidomide to treat lymphoma patients met its primary endpoint. Tafasitamab is an investigational monoclonal antibody in development for blood cancer indications.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: ACHN , OTLK , MOR , JNJ , PFE



More from MT Newswires

Subscribe







MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?